|
1
|
Garipagaoglu M, Munley MT, Hollis D,
Poulson JM, Bentel GC, Sibley G, Anscher MS, Fan M, Jaszczak RJ,
Coleman RE, et al: The effect of patient-specific factors on
radiation-induced regional lung injury. Int J Radiat Oncol Biol
Phys. 45:331–338. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Claude L, Pérol D, Ginestet C, Falchero L,
Arpin D, Vincent M, Martel I, Hominal S, Cordier JF and Carrie C: A
prospective study on radiation pneumonitis following conformal
radiation therapy in non-small-cell lung cancer: Clinical and
dosimetric factors analysis. Radiother Oncol. 71:175–181. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kong FM, Ao X, Wang L and Lawrence TS: The
use of blood biomarkers to predict radiation lung toxicity: A
potential strategy to individualize thoracic radiation therapy.
Cancer Control. 15:140–150. 2008.PubMed/NCBI
|
|
4
|
Abratt RP and Morgan GW: Lung toxicity
following chest irradiation in patients with lung cancer. Lung
Cancer. 35:103–109. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Marks LB, Bentzen SM, Deasy JO, Kong FM,
Bradley JD, Vogelius IS, El Naqa I, Hubbs JL, Lebesque JV,
Timmerman RD, et al: Radiation dose-volume effects in the lung. Int
J Radiat Oncol Biol Phys. 76:(Suppl). S70–S76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rubin P, Finkelstein J and Shapiro D:
Molecular biology mechanisms in the radiation induction of
pulmonary injury syndromes: Interrelationship between the alveolar
macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys.
24:93–101. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morgan GW and Breit SN: Radiation and the
lung: A reevaluation of the mechanisms mediating pulmonary injury.
Int J Radiat Oncol Biol Phys. 31:361–369. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Siva S, MacManus M, Kron T, Best N, Smith
J, Lobachevsky P, Ball D and Martin O: A pattern of early
radiation-induced inflammatory cytokine expression is associated
with lung toxicity in patients with non-small cell lung cancer.
PLoS One. 9:e1095602014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chaturvedi AK, Caporaso NE, Katki HA, Wong
HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ and Engels EA:
C-reactive protein and risk of lung cancer. J Clin Oncol.
28:2719–2726. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hartsell WF, Scott CB, Dundas GS,
Mohiuddin M, Meredith RF, Rubin P and Weigensberg IJ: Can serum
markers be used to predict acute and late toxicity in patients with
lung cancer? Analysis of RTOG 91–03. Am J Clin Oncol. 30:368–376.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dehing-Oberije C, Aerts H, Yu S, De
Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B and Lambin
P: Development and validation of a prognostic model using blood
biomarker information for prediction of survival of non-small-cell
lung cancer patients treated with combined chemotherapy and
radiation or radiotherapy alone (NCT00181519, NCT00573040, and
NCT00572325). Int J Radiat Oncol Biol Phys. 81:360–368. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walker MJ, Zhou C, Backen A, Pernemalm M,
Williamson AJ, Priest LJ, Koh P, Faivre-Finn C, Blackhall FH, Dive
C, et al: Discovery and validation of predictive biomarkers of
survival for non-small cell lung cancer patients undergoing radical
radiotherapy: Two proteins with predictive value. E Bio Medicine.
2:841–850. 2015.
|
|
13
|
Chen Y, Williams J, Ding I, Hernady E, Liu
W, Smudzin T, Finkelstein JN, Rubin P and Okunieff P: Radiation
pneumonitis and early circulatory cytokine markers. Semin Radiat
Oncol. 12(Suppl 1): 26–33. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mazeron R, Etienne-Mastroianni B, Pérol D,
Arpin D, Vincent M, Falchero L, Martel-Lafay I, Carrie C and Claude
L: Predictive factors of late radiation fibrosis: A prospective
study in non-small cell lung cancer. Int J Radiat Oncol Biol Phys.
77:38–43. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wrona A and Jassem J: The new TNM
classification in lung cancer. Pneumonol Alergol Pol. 78:407–417.
2010.(In Polish). PubMed/NCBI
|
|
16
|
Soriano JB, Lamprecht B, Ramírez AS,
Martinez-Camblor P, Kaiser B, Alfageme I, Almagro P, Casanova C,
Esteban C, Soler-Cataluña JJ, et al: Mortality prediction in
chronic obstructive pulmonary disease comparing the GOLD 2007 and
2011 staging systems: A pooled analysis of individual patient data.
Lancet Respir Med. 3:443–450. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miedinger D, Neukomm E, Chhajed PN,
Schnyder A, Naef M, Ackermann M and Leuppi JD: The use of the
Asthma Control Test in general practice and its correlation with
asthma control according to the GINA guidelines. Curr Med Res Opin.
27:2301–2308. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
National Comprehensive Cancer Network
(NCCN), . NCCN Guidelines®. NCCN; Fort Washington, PA, USA:
2015
|
|
19
|
No authors listed: Prescribing, recording,
and reporting photon-beam intensity-modulated radiation therapy
(IMRT): Contents. J ICRU. 10(NP)2010.
|
|
20
|
Faria SL, Aslani M, Tafazoli FS, Souhami L
and Freeman CR: The challenge of scoring radiation-induced lung
toxicity. Clin Oncol (R Coll Radiol). 21:371–375. 2009. View Article : Google Scholar
|
|
21
|
Wolk K, Witte E, Hoffmann U, Doecke WD,
Endesfelder S, Asadullah K, Sterry W, Volk HD, Wittig BM and Sabat
R: IL-22 induces lipopolysaccharide-binding protein in hepatocytes:
A potential systemic role of IL-22 in Crohn's disease. J Immunol.
178:5973–5981. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abdolhosseini M, Sotsky JB, Shelar AP,
Joyce PB and Gorr SU: Human parotid secretory protein is a
lipopolysaccharide-binding protein: Identification of an
anti-inflammatory peptide domain. Mol Cell Biochem. 359:1–8. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villar J, Pérez-Méndez L, Espinosa E,
Flores C, Blanco J, Muriel A, Basaldúa S, Muros M, Blanch L,
Artigas A, et al: GRECIA and GEN-SEP Groups: Serum
lipopolysaccharide binding protein levels predict severity of lung
injury and mortality in patients with severe sepsis. PLoS One.
4:e68182009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dentener MA, Vreugdenhil AC, Hoet PH,
Vernooy JH, Nieman FH, Heumann D, Janssen YM, Buurman WA and
Wouters EF: Production of the acute-phase protein
lipopolysaccharide-binding protein by respiratory type II
epithelial cells: Implications for local defense to bacterial
endotoxins. Am J Respir Cell Mol Biol. 23:146–153. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aupérin A, Le Péchoux C, Rolland E, Curran
WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus
R, et al: Meta-analysis of concomitant versus sequential
radiochemotherapy in locally advanced non-small-cell lung cancer. J
Clin Oncol. 28:2181–2190. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Ruysscher D, Botterweck A, Dirx M,
Pijls-Johannesma M, Wanders R, Hochstenbag M, Dingemans AM, Bootsma
G, Geraedts W, Simons J, et al: Eligibility for concurrent
chemotherapy and radiotherapy of locally advanced lung cancer
patients: A prospective, population-based study. Ann Oncol.
20:98–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
